Performance analysis of 3D brain MRI modalities for brain tumour sub-region segmentation using U-Net architecture Online publication date: Tue, 30-Apr-2024
by Anima Kujur; Zahid Raza
International Journal of Electronic Healthcare (IJEH), Vol. 13, No. 4, 2023
Abstract: Magnetic resonance imaging (MRI) is the most widely used technology for brain tumour diagnosis. T1, T1-weighted with and without a contrast agent, fluid-attenuated inversion recovery (FLAIR), and T2-weighted are some of the numerous MRI imaging types available. This work proposes a framework and measures its effectiveness while taking into account the contribution made by each MRI modality in the segmentation of brain tumour sub-regions. The proposed approach has four phases. First phase corresponds to the data collection followed by data pre-processing in the second phase. The third phase entails the implementation of a deep learning model called the U-Net architecture, a form of convolutional neural networks (CNN). The fourth phase evaluates the framework using the popular measures, viz., intersection over union, dice coefficient for each tumour region, sensitivity, and specificity. Simulation study reveals that some MRI modalities contribute comparatively less than the peer MRI modalities to the final performance of the model. Further, it is established that MRIs individually do not perform well but the combination reports an improved performance.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Electronic Healthcare (IJEH):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com